TEVA PHARMACEUTICAL INDUSTRIES LIMITED Deferred Tax Liabilities, Gross
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Deferred Tax Liabilities, Gross of $296.00 million as of 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-03
- 2025-12-31: Deferred Tax Liabilities, Gross $296.00M.
- 2024-12-31: Deferred Tax Liabilities, Gross $483.00M.
- 2023-12-31: Deferred Tax Liabilities, Gross $606.00M.
- 2022-12-31: Deferred Tax Liabilities, Gross $548.00M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $296.00M 10-K · filed 2026-02-03 |
| 2024-12-31 | $483.00M 10-K · filed 2026-02-03 |
| 2023-12-31 | $606.00M 10-K · filed 2025-02-05 |
| 2022-12-31 | $548.00M 10-K · filed 2024-02-12 |
| 2021-12-31 | $784.00M 10-K · filed 2023-02-10 |
| 2020-12-31 | $964.00M 10-K · filed 2022-02-09 |
| 2019-12-31 | $1.10B 10-K · filed 2021-02-10 |
| 2018-12-31 | $2.14B 10-K · filed 2020-02-21 |
| 2017-12-31 | $3.28B 10-K · filed 2019-02-19 |